MakroCare Exhibits at Asia Regulatory Conference 2013, Singapore
Meet MakroCare, an International Development and Commercialization services firm at Asia Regulatory Conference 2013, Singapore
Newark, NJ (I-Newswire) January 18, 2013 - Meet MakroCare, one of the sponsors of the Asia Regulatory Conference 2013 held at Raffles Convention Centre, Singapore on 28-30 January, 2013.
Asia Regulatory Conference 2013 offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
This conference will provide a forum to:
•Facilitate discussion on common issues in the regulatory and technical areas in Asia
•Encourage greater convergence of regulatory requirements in Asia
•Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Conference speakers will include top-level regulatory authorities from several Asian countries as well as leading experts in the ICH process. In addition, speakers will include representatives of WHO, various regulatory agencies from other regions and the multinational and local pharmaceutical industry.
MakroCare is sponsoring and exhibiting, Visitors/Delegates are welcome to visit us in Asia Regulatory Conference 2013, Singapore, to know more about our Regulatory, Quality & Risk Management Services.
MakroCare is an international drug development and commercialization services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction supporting from USA, Europe and Asia. MakroCare has 5 subsidiaries/divisions – Consulting, CRO, SMO, DDi and Commercialization. MakroCare has teams positioned worldwide in these divisions supporting product life cycle management, regulatory affairs, risk management, regulatory compliance, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostat, SAS programming), Medical Writing (Regulatory, Clinical), QA audits, Drug safety / Pharmacovigilance, Site management, Patient Recruitment, Informatics (EDC, CTMS, IVRS), Commercialization, and Marketing/Sales.
One Washington Park, Suite 1303
Phone : (888) 931 0060
Tags:Clinical Research Singapore Clinical Research India CRO Singapore Medical Device Regulatory Affairs Medical Device Regulatory India
Published in:Science and Research
Published On:January 18, 2013
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
Aqua Feed Market Worth $106 Billion By 2018
F1000Research Joins OASPA and COPE, and Is Listed in DOAJ and SHERPA/RoMEO
Opening Asia Based International Open Access Journal of Science, Science Postprint, on June 11th.
Microbial Enhanced Oil Recovery [MEOR] Spells MORE Oil
Lightning As A 'Photographer' – Mysterious Appearance Of Ghostly Images On Windowpanes Explained